Author details

Full Name

Anders Jacobsen Skanderup

Affiliation

ORCID

Career Start Year

1990

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36918265	Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.	Gut	2023
35817555	Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.	Gut	2023
36436331	PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer.	European Journal of Cancer	2023
37580755	Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.		2023
37461096	Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.		2023
37041233	PUREE: accurate pan-cancer tumor purity estimation from gene expression data.		2023
35199060	Obtaining spatially resolved tumor purity maps using deep multiple instance learning in a pan-cancer study.	Patterns	2022
35773407	Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer.	Nat Genet	2022
36240473	Clinical and Genomic Features of Exon 20 Insertion Mutations and Characterization of Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer.	JCO Precision Oncology	2022
35382356	Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study.	National Science Review	2022
36083902	Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients.	Science advances	2022
35751808	Accurate Ensemble Prediction of Somatic Mutations with SMuRF2.	Methods in Molecular Biology	2022
35869060	Accurate somatic variant detection using weakly supervised deep learning.	Nature Communications	2022
35415893	A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects.	International Journal of Cancer	2022
35545044	A pan-cancer metabolic atlas of the tumor microenvironment.	Cell Reports	2022
36426287	A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC.	JTO Clinical and Research Reports	2022
34433583	Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.	Gut	2022
35121958	Targeting the developmental origins of cancer.	Nature Cancer	2021
33911076	The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype.	Nat Commun	2021
33862587	Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'.	eBioMedicine	2021
33850132	Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden.	Nature Communications	2021
34261696	Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities.	Clinical Cancer Research	2021
34250396	Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.	JCO Precision Oncology	2021
33547160	Pan-Cancer Analysis of Ligand-Receptor Cross-talk in the Tumor Microenvironment.	Cancer Research	2021
34739062	Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.	JAMA network open	2021
31542774	Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent and enhancer hijacking in primary gastric adenocarcinoma.	Gut	2020
32015526	Genomic landscape of lung adenocarcinoma in East Asians.	Nature Genetics	2020
32364535	Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.	J Clin Invest	2020
32124310	Ensemble-Based Somatic Mutation Calling in Cancer Genomes.	Methods in Molecular Biology	2020
32550006	MutSpot: detection of non-coding mutation hotspots in cancer genomes.	npj Genomic Medicine	2020
31417090	Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.	Nat Commun	2019
30649191	SMuRF: portable and accurate ensemble prediction of somatic mutations.		2019
29670109	Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.	Nature Communications	2018
30521023	Advances in genomic hepatocellular carcinoma research.	GigaScience	2018
28029648	Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.	Oncotarget	2017
28408461	Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations.	Blood	2017
28920960	Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.	Nature Medicine	2017
29212036	Î¿Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.	Cell Rep	2017
27108420	Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.	World Journal of Urology	2017
27713405	Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.	Nat Commun	2016
26505625	Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.	Cancer	2016
27601543	Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.	J Clin Oncol	2016
24882579	miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2.	Oncogene	2015
25748237	Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.	Neoplasia	2015
25908244	The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence.	Nat Commun	2015
25676555	TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.	Mod Pathol	2015
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
25261935	Genome-wide analysis of noncoding regulatory mutations in cancer.	Nat Genet	2014
25546138	Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.	Genes (Basel)	2014
23550210	Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.	Sci Signal	2013